USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Risen (SUZHOU) Pharma Tech Co., Ltd.

USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Risen ranks #19,092 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.

#19,092
of 49,997 US assignees by volume
Top 28%
by Innovation Score (43.4/100)
18.3
avg claims per patent
+900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19092 · Foreign Corporation #19,092 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,092/49,997
  • PHOTO-FINISH Rideshare Displays
  • CPC-FOCUS A61P · 10 areas
  • INNOV-PAR 43.4/100
  • CLAIMS-RICH 18.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +900% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rideshare Displays, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Risen’s 43.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Risen

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Risen's Innovation Score is 43.4/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Risen?

Each dot is one of Risen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Risen’s own 18.3 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Risen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 0510152025 Granted patents (volume) Avg claims / patent Rideshare Displays, Inc. - 15, 9.87Rideshare DisplaysRiedel Communications International GMBH - 15, 11Riedel Communicat…Riegl Laser Measurement Systems GMBH - 15, 13.07Riegl Laser Measu…Risc Networks, LLC - 15, 19.6Risc NetworksRofin-sinar Technologies LLC - 15, 18.87Rofin-sinarRoger Vivier S.P.A. - 15, 1Roger Vivier S P ARolic Technologies AG - 15, 16.13RolicRPS Group, Inc. - 15, 16.27RPS GroupRisen (SUZHOU) Pharma Tech Co., Ltd. - 15, 18.33Risen (Suzhou) Ph…
Risen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Risen's grants concentrate

Risen (SUZHOU) Pharma Tech Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 86.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2019. By volume, Risen sits between Rideshare Displays, Inc. and RPS Group, Inc..

Risen's three-year grant acceleration

Risen (SUZHOU) Pharma Tech Co., Ltd. shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Risen's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Risen holds 15 patents at rank #19,070, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Risen

By rank, the assignees closest to #19,070 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Risen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Risen, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Risen ranks #1,479 of 6,058 assignees by patent count in that subclass.

Risen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201920212022202320242025 4
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Risen (SUZHOU) Pharma Tech Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 6.7%
2021 3 20.0%
2022 2 13.3%
2023 4 26.7%
2024 1 6.7%
2025partial year 4 26.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Risen (SUZHOU) Pharma Tech Co., Ltd.'s patent record in context - here's where to go next.

  • Risen (SUZHOU) Pharma Tech Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #19,092 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Risen (SUZHOU) Pharma Tech Co., Ltd. against Rideshare Displays, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.